BIAF Earnings

Quarterly EPS
$-72.60
Q3 2024
$-49.85
Q4 2024
$-2.40
Q1 2025
$-76.05
Q2 2025
$-71.10
Q3 2025
$0.00
Q4 2025
$-12.15
Q1 2026
$-9.60
Q2 2026
Latest Revenue1.5M
Latest Net Income-3366082
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$9.601.5M-3366082+19.0%+87.4%
Q1 2026-$12.151.4M-3630610-27.1%-406.3%
Q4 20251.6M-3137466-27.8%
Q3 2025-$71.101.4M-5051084-38.5%+2.1%
Q2 2025-$76.051.3M-4060787-47.1%+11.1%
Q1 2025-$2.401.9M-2660417-23.0%+97.3%
Q4 2024-$49.852.2M-2966897-0.3%+56.4%
Q3 2024-$72.602.4M-2000840+687.4%+37.9%
Q2 2024-$85.502.4M-2110279
Q1 2024-$90.002.4M-1961815
Q4 2023-$114.352.2M-2373164
Q3 2023-$117.00298.5K-2290884
bioAffinity Technologies (BIAF) — Earnings